ArticleInflammatory bowel diseases2025

MK2 Inhibition in CD4+ T Cells Protects Against IFNγ and IL-17A, Chronic Inflammation, and Fibrosis in Inflammatory Bowel Disease Models.

Cody S Howe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.